Abstract:Though chemotherapeutics has been one of the most widely used treatments for tumor therapy, it is still heavily limited due to its poor pharmacokinetics, undesirable intracellular uptake and inevitable side effects. In order to overcome these barriers, various functional groups have been introduced in drug delivery system to enhance the therapeutic efficiency of chemotherapy. In this study, a novel drug delivery system for tumor nuclear accurate targeting was designed in order to achieve precise tumor nuclear treatment. The chemotherapeutic drug (doxorubicin, DOX) was encapsulated in amphiphilic dendritic peptide with nuclear localization function to form a regular nanoparticle DD. After that, electronegative hyaluronic acid (HA) with ability of tumor targeting was coated on the surface of nanoparticle DD via electrostatic interaction to form tumor nuclear targeting drug delivery system HDD. The presence of HA endowed HDD with the tumor targeting ability and charge shielding effect, which could increase the stability of nanodrug, promote the specific internalization by tumor cells and reduce the non-specific uptake by normal tissue/cells. Furthermore, it was found that the drug delivery system HDD could realize the facile internalization by tumor cells via CD44 receptor-mediated recognition. After the degradation of HA shell by hyaluronidase (HAase) in endosome, the nuclear targeted nanodrug DD was exposed, and DOX was carried to the region of nuclear accurately by inheriting the ability from nuclear-targeted peptide. The precise targeting of drug to nuclei could be beneficial to the improvement of drug utilization as well as the suppression of tumor cells. The characteristics of this tumor nuclear accurate targeting drug delivery system, including particle sizes, zeta potential, drug loading capacity, drug release behavior, cellular uptake and antitumor efficacy, were evaluated. All of the studies confirmed that the precise tumor nuclear targeting drug delivery system HDD displayed prominent antitumor efficacy with insignificant adverse effects to normal cells in vitro, which indicated that the precise tumor nuclear targeting delivery system supplies a useful strategy for tumor therapy.

Dendronized hyaluronic acid-docetaxel conjugate as a stimuli-responsive nano-agent for breast cancer therapy

Reduction-responsive Core-Crosslinked Hyaluronic Acid-B-poly(trimethylene Carbonate-Co-dithiolane Trimethylene Carbonate) Micelles: Synthesis and CD44-mediated Potent Delivery of Docetaxel to Triple Negative Breast Tumor in Vivo

Hyaluronic Acid-Functionalized Half-Generation of Sectorial Dendrimers for Anticancer Drug Delivery and Enhanced Biocompatibility.

Enhancing Therapeutic Effects of Docetaxel-Loaded Dendritic Copolymer Nanoparticles by Co-Treatment with Autophagy Inhibitor on Breast Cancer

Dendron-polymer Hybrid Mediated Anticancer Drug Delivery for Suppression of Mammary Cancer

Glycodendron/pyropheophorbide-a (Ppa)-functionalized hyaluronic acid as a nanosystem for tumor photodynamic therapy

Redox-responsive Hyaluronic Acid-Based Nanoparticles for Targeted Photodynamic Therapy/chemotherapy Against Breast Cancer.

Injectable And Self-Healing Thermosensitive Magnetic Hydrogel For Asynchronous Control Release Of Doxorubicin And Docetaxel To Treat Triple-Negative Breast Cancer

Biodegradable Self-Assembled Nanoparticles of Poly (D,l-Lactide-co-glycolide)/hyaluronic Acid Block Copolymers for Target Delivery of Docetaxel to Breast Cancer

Facile Strategy by Hyaluronic Acid Functional Carbon Dot-Doxorubicin Nanoparticles for CD44 Targeted Drug Delivery and Enhanced Breast Cancer Therapy

Dendronized Heparin-Doxorubicin Conjugate Based Nanoparticle As Ph-Responsive Drug Delivery System for Cancer Therapy.

Oligo Hyaluronan-Coated Silica/Hydroxyapatite Degradable Nanoparticles for Targeted Cancer Treatment

Delivery of Mitochondriotropic Doxorubicin Derivatives Using Self-Assembling Hyaluronic Acid Nanocarriers in Doxorubicin-Resistant Breast Cancer

A Multi-functional Drug Delivery System Based on Dendritic Peptide for Tumor Nuclear Accurate Targeting Therapy

Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects.

A Novel Dextran-Based Dual Drug Conjugate Targeted Tumors with High Biodistribution Ratio of Tumors to Normal Tissues

Tumor-targeting Delivery of Hyaluronic Acid–platinum(iv) Nanoconjugate to Reduce Toxicity and Improve Survival

Polysaccharide-Gold Nanocluster Supramolecular Conjugates As a Versatile Platform for the Targeted Delivery of Anticancer Drugs

Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies.

CD44-Targeted Multifunctional Nanomedicines Based on a Single-Component Hyaluronic Acid Conjugate with All-Natural Precursors: Construction and Treatment of Metastatic Breast Tumors in Vivo .

Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/Neu Overexpressed Human Breast Cancer Cells